Cargando…
Erectile function after WST11 vascular-targeted photodynamic therapy for low-risk prostate cancer treatment
Vascular-targeted photodynamic therapy (VTP) using padeliporfin is currently assessed as a low-risk prostate cancer (LRPCa) treatment. The aim of this study was to assess erectile function outcomes of VTP for LRPCa treatment. We prospectively included all patients treated with VTP for LRPCa. The pri...
Autores principales: | Chelly, Samuel, Maulaz, Pierre, Bigot, Pierre, Azzouzi, Abdel Rahmene, Lebdai, Souhil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523613/ https://www.ncbi.nlm.nih.gov/pubmed/31939351 http://dx.doi.org/10.4103/aja.aja_138_19 |
Ejemplares similares
-
Vascular-targeted photodynamic therapy with TOOKAD(®) Soluble in localized prostate cancer: standardization of the procedure
por: Azzouzi, Abdel-Rahmene, et al.
Publicado: (2015) -
Impact of retrograde flexible ureteroscopy and intracorporeal lithotripsy on kidney functional outcomes
por: Hoarau, Nicolas, et al.
Publicado: (2015) -
Rectal Metastasis of Prostate Cancer: About a Case
por: Venara, Aurelien, et al.
Publicado: (2010) -
WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice
por: Neuschmelting, Volker, et al.
Publicado: (2018) -
Is prostatic artery embolization a relevant treatment after a failed alpha-blocker monotherapy?
por: Lebdai, Souhil
Publicado: (2023)